{"id":20634,"date":"2025-12-07T19:05:29","date_gmt":"2025-12-07T18:05:29","guid":{"rendered":"https:\/\/thesmartcityjournal.cibeles.net\/sin-categorizar\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\/"},"modified":"2025-12-07T19:07:23","modified_gmt":"2025-12-07T18:07:23","slug":"bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco","status":"publish","type":"post","link":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco","title":{"rendered":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco"},"content":{"rendered":"<p><em>Se trata de pacientes hipersensibilizados con anticuerpos espec\u00edficos contra la mayor\u00eda de ant\u00edgenos del sistema HLA (presente en el donante) para los que el riesgo de rechazo es inmediato e irreversible, lo que les aboca a la di\u00e1lisis de larga duraci\u00f3n<\/em><\/p>\n<p>Transfusiones, embarazos o trasplantes previos son responsables de la hiperactividad del sistema inmunitario de entre un 15% y un 20% de las personas que est\u00e1n en la lista de espera para recibir un trasplante de ri\u00f1\u00f3n. Aunque estas personas ocupan un lugar prioritario en la lista, algunas de ellas tienen un n\u00famero tan elevado de anticuerpos contra los distintos ant\u00edgenos HLA que hace casi imposible encontrar a un donante compatible, de forma que deben continuar con la di\u00e1lisis para siempre.<\/p>\n<p>El pasado mes de septiembre, con el visto bueno de las autoridades sanitarias, se trasplant\u00f3 al Hospital de Bellvitge por primera vez en Catalu\u00f1a fuera de un ensayo cl\u00ednico un ri\u00f1\u00f3n a una persona hipersensibilizada en el centro gracias a la administraci\u00f3n de imlifidasa. El paciente llevaba m\u00e1s de 9 a\u00f1os en tratamiento con di\u00e1lisis y se hipersensibiliz\u00f3 despu\u00e9s de perder un trasplante previo. Tres meses despu\u00e9s del trasplante, el paciente ha tenido una excelente evoluci\u00f3n, sin complicaciones ni signos de rechazo a la biopsia de control.<\/p>\n<p>La imlifidasa es una enzima derivada de una bacteria llamada\u00a0<em>Streptococcus pyogenes<\/em>, responsable de la faringitis estreptoc\u00f3cica. En este caso, sin embargo una enzima espec\u00edfica de esta bacteria funciona descomponiendo los anticuerpos generados en exceso y responsables del rechazo posterior al \u00f3rgano.<\/p>\n<p>En el protocolo para la realizaci\u00f3n de la primera intervenci\u00f3n de estas caracter\u00edsticas, han participado profesionales de los servicios de Nefrolog\u00eda, Farmacia y Anestesiolog\u00eda, adem\u00e1s de Enfermer\u00eda y Coordinaci\u00f3n de Trasplantes del Hospital de Bellvitge.<\/p>\n<p>Tal y como explica el Dr. Edoardo Melilli, jefe de secci\u00f3n del Servicio de Nefrolog\u00eda del Hospital de Bellvitge, \u201cel f\u00e1rmaco se aplica por v\u00eda endovenosa y destruye temporalmente el exceso de anticuerpos y nos abre una ventana de 3 o 4 d\u00edas para realizar el trasplante, evitando el rechazo inmediato y haci\u00e9ndolo viable gracias al tratamiento con inmunosupresores\u201d.<\/p>\n<p>La Dra. Ariadna Padulles, jefe de secci\u00f3n del Servicio de Farmacia a\u00f1ade que una vez administrada la imlifidasa, se repite la prueba de la simulaci\u00f3n del trasplante (<em>crossmatch<\/em>) en un plazo de pocas horas para confirmar la negatividad. Si el resultado es negativo, el paciente puede recibir el trasplante con riesgo reducido de rechazo hiperagudo. \u00abPor esta raz\u00f3n, la coordinaci\u00f3n estricta entre el Servicio de Nefrolog\u00eda, Inmunolog\u00eda y Farmacia es esencial para garantizar el cumplimiento de los tiempos cr\u00edticos y evitar demoras que podr\u00edan incrementar el riesgo de disfunci\u00f3n retardada del injerto\u00bb, explica la Dra. Padull\u00e9s. En casos infrecuentes, el\u00a0<em>crossmatch<\/em>\u00a0puede permanecer positivo despu\u00e9s de la primera administraci\u00f3n, lo que puede hacer necesaria una segunda dosis del f\u00e1rmaco.<\/p>\n<p>De esta forma, los pacientes hipersensibilizados pueden encontrar en la imlifidasa una alternativa viable para recibir un trasplante renal. Se trata de un perfil muy concreto de pacientes, ya que aparte del exceso de anticuerpos no deben tener muchas comorbilidades ni fragilidad y deben poder tolerar el tratamiento con inmunosupresores m\u00e1s agresivos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Se trata de pacientes hipersensibilizados con anticuerpos espec\u00edficos contra la mayor\u00eda de ant\u00edgenos del sistema HLA (presente en el donante) para los que el riesgo de rechazo es inmediato e irreversible, lo que les aboca a la di\u00e1lisis de larga duraci\u00f3n Transfusiones, embarazos o trasplantes previos son responsables de la hiperactividad del sistema inmunitario de\u2026<\/p>\n","protected":false},"author":2,"featured_media":20633,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_scj_primary_category_id":91,"_scj_featured":false,"_scj_featured_from":"","_scj_featured_until":"","_scj_featured_order":0,"_scj_visibility_class":"current","_scj_layout_family":"standard","_scj_article_style":"","_scj_display_overrides":[],"_scj_intro_image_id":20633,"_scj_intro_alt":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco","_scj_intro_caption":"","_scj_intro_class":"","_scj_intro_float":"","_scj_full_image_id":20633,"_scj_full_alt":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco","_scj_full_caption":"","_scj_full_class":"","_scj_full_float":"","_scj_media_type":"","_scj_media_provider":"","_scj_media_external_id":"","_scj_media_url":"","_scj_media_poster_id":0,"_scj_media_width":0,"_scj_media_height":0,"_scj_media_aspect_ratio":"","_scj_media_description":"","_scj_gallery_items":[],"_scj_related_post_ids":[],"_scj_additional_authors":[],"scj_layout_family":"standard","scj_media_provider":"","scj_media_url":"","scj_full_caption":"","footnotes":""},"categories":[91],"tags":[3082,3080,3081,3083,3084,3079],"class_list":["post-20634","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthtech","tag-hospital-bellvitge","tag-imlifidasa","tag-pacientes-hipersensibilizados","tag-rechazo-inmunologico","tag-terapia-innovadora","tag-trasplante-renal"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco - thesmartcityjournal.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco - thesmartcityjournal.com\" \/>\n<meta property=\"og:description\" content=\"Se trata de pacientes hipersensibilizados con anticuerpos espec\u00edficos contra la mayor\u00eda de ant\u00edgenos del sistema HLA (presente en el donante) para los que el riesgo de rechazo es inmediato e irreversible, lo que les aboca a la di\u00e1lisis de larga duraci\u00f3n Transfusiones, embarazos o trasplantes previos son responsables de la hiperactividad del sistema inmunitario de\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\" \/>\n<meta property=\"og:site_name\" content=\"thesmartcityjournal.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thesmartcityjournal\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-07T18:05:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-07T18:07:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2025\/12\/trasplante-renal-imlifidasa-bellvitge.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1279\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:site\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\"},\"author\":{\"@type\":\"Organization\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/author\\\/smart-city\"},\"headline\":\"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco\",\"datePublished\":\"2025-12-07T18:05:29+00:00\",\"dateModified\":\"2025-12-07T18:07:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\"},\"wordCount\":578,\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/trasplante-renal-imlifidasa-bellvitge.jpg\",\"keywords\":[\"hospital bellvitge\",\"imlifidasa\",\"pacientes hipersensibilizados\",\"rechazo inmunol\u00f3gico\",\"terapia innovadora\",\"trasplante renal\"],\"articleSection\":[\"Healthtech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\",\"name\":\"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco - thesmartcityjournal.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/trasplante-renal-imlifidasa-bellvitge.jpg\",\"datePublished\":\"2025-12-07T18:05:29+00:00\",\"dateModified\":\"2025-12-07T18:07:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/trasplante-renal-imlifidasa-bellvitge.jpg\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/trasplante-renal-imlifidasa-bellvitge.jpg\",\"width\":1920,\"height\":1279,\"caption\":\"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/healthtech\\\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/\",\"name\":\"thesmartcityjournal.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#organization\",\"name\":\"thesmartcityjournal.com\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"width\":346,\"height\":91,\"caption\":\"thesmartcityjournal.com\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/thesmartcityjournal\",\"https:\\\/\\\/x.com\\\/SmartCityJour_\",\"https:\\\/\\\/www.instagram.com\\\/thesmartcityjournal_\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@thesmartcityjournal\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/the-smart-city-journal\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCIPTMzK206pVFxMNjO7SSxw\"]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/#\\\/schema\\\/person\\\/39c9da1aeac1b5c2d179ef9e4e293cf4\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3n de The Smart City Journal\"},\"description\":\"Equipo de redacci\u00f3n de The Smart City Journal.\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es\\\/author\\\/smart-city\"},{\"@type\":[\"Organization\",\"NewsMediaOrganization\"],\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#organization\"},{\"@type\":\"SiteNavigationElement\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#site-navigation\",\"cssSelector\":[\".cib-main-menu\"]},{\"@type\":\"WPHeader\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#header\",\"cssSelector\":[\".cib-header\"]},{\"@type\":\"WPFooter\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/es#footer\",\"cssSelector\":[\".cib-footer\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco - thesmartcityjournal.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco","og_locale":"es_ES","og_type":"article","og_title":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco - thesmartcityjournal.com","og_description":"Se trata de pacientes hipersensibilizados con anticuerpos espec\u00edficos contra la mayor\u00eda de ant\u00edgenos del sistema HLA (presente en el donante) para los que el riesgo de rechazo es inmediato e irreversible, lo que les aboca a la di\u00e1lisis de larga duraci\u00f3n Transfusiones, embarazos o trasplantes previos son responsables de la hiperactividad del sistema inmunitario de\u2026","og_url":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco","og_site_name":"thesmartcityjournal.com","article_publisher":"https:\/\/www.facebook.com\/thesmartcityjournal","article_published_time":"2025-12-07T18:05:29+00:00","article_modified_time":"2025-12-07T18:07:23+00:00","og_image":[{"width":1920,"height":1279,"url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2025\/12\/trasplante-renal-imlifidasa-bellvitge.jpg","type":"image\/jpeg"}],"author":"Redacci\u00f3n de The Smart City Journal","twitter_card":"summary_large_image","twitter_creator":"@SmartCityJour_","twitter_site":"@SmartCityJour_","twitter_misc":{"Escrito por":"Redacci\u00f3n de The Smart City Journal","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#article","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco"},"author":{"@type":"Organization","name":"Redacci\u00f3n de The Smart City Journal","url":"https:\/\/www.thesmartcityjournal.com\/es\/author\/smart-city"},"headline":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco","datePublished":"2025-12-07T18:05:29+00:00","dateModified":"2025-12-07T18:07:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco"},"wordCount":578,"publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#organization"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2025\/12\/trasplante-renal-imlifidasa-bellvitge.jpg","keywords":["hospital bellvitge","imlifidasa","pacientes hipersensibilizados","rechazo inmunol\u00f3gico","terapia innovadora","trasplante renal"],"articleSection":["Healthtech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco","url":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco","name":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco - thesmartcityjournal.com","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2025\/12\/trasplante-renal-imlifidasa-bellvitge.jpg","datePublished":"2025-12-07T18:05:29+00:00","dateModified":"2025-12-07T18:07:23+00:00","breadcrumb":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#primaryimage","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2025\/12\/trasplante-renal-imlifidasa-bellvitge.jpg","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2025\/12\/trasplante-renal-imlifidasa-bellvitge.jpg","width":1920,"height":1279,"caption":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thesmartcityjournal.com\/es\/healthtech\/bellvitge-realiza-un-trasplante-renal-a-un-paciente-hasta-ahora-inoperable-gracias-a-un-nuevo-farmaco#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thesmartcityjournal.com\/es"},{"@type":"ListItem","position":2,"name":"Bellvitge realiza un trasplante renal a un paciente hasta ahora inoperable gracias a un nuevo f\u00e1rmaco"}]},{"@type":"WebSite","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#website","url":"https:\/\/www.thesmartcityjournal.com\/es\/","name":"thesmartcityjournal.com","description":"","publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thesmartcityjournal.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#organization","name":"thesmartcityjournal.com","url":"https:\/\/www.thesmartcityjournal.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","width":346,"height":91,"caption":"thesmartcityjournal.com"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thesmartcityjournal","https:\/\/x.com\/SmartCityJour_","https:\/\/www.instagram.com\/thesmartcityjournal_\/","https:\/\/www.tiktok.com\/@thesmartcityjournal","https:\/\/www.linkedin.com\/company\/the-smart-city-journal\/","https:\/\/www.youtube.com\/channel\/UCIPTMzK206pVFxMNjO7SSxw"]},{"@type":"Organization","@id":"https:\/\/www.thesmartcityjournal.com\/es\/#\/schema\/person\/39c9da1aeac1b5c2d179ef9e4e293cf4","name":"Redacci\u00f3n de The Smart City Journal","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"Redacci\u00f3n de The Smart City Journal"},"description":"Equipo de redacci\u00f3n de The Smart City Journal.","url":"https:\/\/www.thesmartcityjournal.com\/es\/author\/smart-city"},{"@type":["Organization","NewsMediaOrganization"],"@id":"https:\/\/www.thesmartcityjournal.com\/es#organization"},{"@type":"SiteNavigationElement","@id":"https:\/\/www.thesmartcityjournal.com\/es#site-navigation","cssSelector":[".cib-main-menu"]},{"@type":"WPHeader","@id":"https:\/\/www.thesmartcityjournal.com\/es#header","cssSelector":[".cib-header"]},{"@type":"WPFooter","@id":"https:\/\/www.thesmartcityjournal.com\/es#footer","cssSelector":[".cib-footer"]}]}},"_links":{"self":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/posts\/20634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/comments?post=20634"}],"version-history":[{"count":0,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/posts\/20634\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/media\/20633"}],"wp:attachment":[{"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/media?parent=20634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/categories?post=20634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/es\/wp-json\/wp\/v2\/tags?post=20634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}